美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BIOCARDIA INC

0.0061

0.0000

成交量：- -

成交額：- -

市值：4.10萬

市盈率：0.00

高：0.0061

開：0.0061

低：0.0061

收：0.0061

52周最高：0.0061

52周最低：0.0061

股本：672.50萬

流通股本：313.34萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-3.1995

每股收益(LYR):-3.2801

淨資產收益率：-829.13%

總資產收益率：-176.83%

市淨率：0.05

市盈率(LYR):0.00

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

BIOCARDIA INC

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.biocardia.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Biocardia, Inc.於1994年1月12日在特拉華州註冊成立。該公司是一家臨床階段的再生醫學公司，為具有大量未滿足的醫療需求的心血管疾病開發新的治療藥物。他們的主要治療候選藥物是研究性CardiAMP細胞治療系統，該系統提供自體骨髓衍生細胞療法（使用患者自身細胞）治療兩種臨床適應症：心臟病發作和慢性心肌缺血后發生的心力衰竭。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BCDAW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"BCDAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDAW\",,,,,undefined,":{"symbol":"BCDAW","market":"US","secType":"STK","nameCN":"BIOCARDIA INC","latestPrice":0.0061,"timestamp":1773172800000,"preClose":0.0061,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":3133364,"shares":6725025,"eps":-3.199549,"marketStatus":"未開盤","change":0,"latestTime":"03-10 16:00:00 EDT","open":0.0061,"high":0.0061,"low":0.0061,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.199549,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773216000000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0061,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCDAW\",,,,,undefined,":{"symbol":"BCDAW","floatShares":3133364,"roa":"-176.83%","roe":"-829.13%","lyrEps":-3.280116,"shares":6725025,"dividePrice":0,"high":0.0061,"amplitude":0,"preClose":0.0061,"low":0.0061,"week52Low":0.0061,"pbRate":"0.05","week52High":0.0061,"institutionHeld":0.0108,"latestPrice":0.0061,"eps":-3.199549,"divideRate":0,"volume":0,"delay":0,"ttmEps":-3.199549,"open":0.0061,"prevYearClose":0.0061,"prevWeekClose":0.0061,"prevMonthClose":0.0061,"prevQuarterClose":0.0061,"fiveDayClose":0.0061,"twentyDayClose":0.0061,"sixtyDayClose":0.0061},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCDAW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-11","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-08-05","symbol":"BCDAW","reason":null,"defaultRemindTime":1722864600000,"announcedDate":"2024-08-02","type":"delisting","dateTimestamp":1722830400000},{"market":"US","date":"2022-08-10","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1660104000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-05-11","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1652241600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-03-29","symbol":"BCDAW","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1648526400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCDAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCDAW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0195},{"period":"3month","weight":-0.0151},{"period":"6month","weight":0.0297},{"period":"1year","weight":0.208},{"period":"ytd","weight":-0.007}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Biocardia, Inc.於1994年1月12日在特拉華州註冊成立。該公司是一家臨床階段的再生醫學公司，為具有大量未滿足的醫療需求的心血管疾病開發新的治療藥物。他們的主要治療候選藥物是研究性CardiAMP細胞治療系統，該系統提供自體骨髓衍生細胞療法（使用患者自身細胞）治療兩種臨床適應症：心臟病發作和慢性心肌缺血后發生的心力衰竭。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.086278},{"month":2,"riseRate":0.428571,"avgChangeRate":0.215058},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.116427},{"month":4,"riseRate":0.5,"avgChangeRate":0.079462},{"month":5,"riseRate":0.5,"avgChangeRate":-0.016368},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.073415},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.250249},{"month":8,"riseRate":0.5,"avgChangeRate":0.106085},{"month":9,"riseRate":0.571429,"avgChangeRate":0.276836},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.085079},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.015362},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.038306}],"exchange":"NASDAQ","name":"BIOCARDIA INC","nameEN":"BIOCARDIA INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BCDAW\",market:\"US\",,,undefined,":null}}